Workshop Course track
AASLD/NASPGHAN, Part 1: Immune-Mediated Pediatric Liver Disease—From Phenotype to Precision Therapy
Sat, Nov 7, 2026 · 8:00–9:30 AM MST Convention Center: Bluebird Ballroom 3DEF, Colorado Convention Center
About this session
The diagnosis and management of autoimmune hepatitis in children have remained largely unchanged for decades. Jointly planned by the American Association for the Study of Liver Diseases and the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition, this informative session highlights advances in immunophenotyping and biomarker discovery, and explores emerging approaches to the management of refractory disease, and autoimmune hepatitis in special pediatric populations.
Speakers
-
University of Texas Southwestern Medical Center
Chair
-
Ann and Robert H. Lurie Children's Hospital of Chicago
Speaker
-
Vanderbilt University Medical center
Speaker
-
Hospital Papa Giovanni XXIII, Bergamo.
Speaker
-
Cincinnati Children's Hospital Medical Center
Moderator
Reviews of this session
No reviews yet
Were you in the room? Reviews are open until Nov 9, 2027.